Home / PARP8 Knockout Cell Lines

PARP8 Knockout Cell Lines

Gene: PARP8

Official Full Name: poly(ADP-ribose) polymerase family member 8provided by HGNC

Gene Summary: Enables NAD+-protein ADP-ribosyltransferase activity. Involved in protein auto-ADP-ribosylation. Predicted to be active in endoplasmic reticulum tubular network and nuclear envelope. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO15351 PARP8 Knockout cell line (HeLa) Human PARP8 1:3~1:6 Negative Online Inquiry
KO15352 PARP8 Knockout cell line (HCT 116) Human PARP8 1:2~1:4 Negative Online Inquiry
KO15353 PARP8 Knockout cell line (HEK293) Human PARP8 1:3~1:6 Negative Online Inquiry

Background

PARP8 Gene Knockout Cell Lines are genetically engineered cell models designed to lack the expression of the PARP8 gene, which encodes a member of the poly(ADP-ribose) polymerase family, known to be involved in various cellular processes including DNA damage response and chromatin remodeling. These knockout cell lines are essential tools for researchers aiming to dissect the specific roles of PARP8 in cellular signaling pathways, drug response, and disease mechanisms.

The key function of PARP8 within the cell revolves around its involvement in modulating DNA repair mechanisms and influencing apoptosis. By understanding the perturbations that arise upon PARP8 knockout, scientists can elucidate its contribution to genomic stability and potential resistance to therapeutic agents. The mechanism of action is rooted in the decoupling of PARP8 from the cellular machinery, allowing researchers to observe downstream effects on cell viability, proliferation, and stress responses.

The scientific importance of PARP8 Gene Knockout Cell Lines lies in their application in both basic and applied research, including cancer biology, neurology, and developmental biology. They enable scientists to investigate the therapeutic implications of targeting PARP8 in tumor contexts, particularly in understanding resistance mechanisms to PARP inhibitors, thus paving the way for novel treatment strategies.

What sets our PARP8 Gene Knockout Cell Lines apart from competing products is our commitment to validated genetic modifications and the availability of comprehensive characterizations of the cellular phenotype post-knockout. This rigor ensures that researchers can trust their results, reducing variability and increasing reproducibility in experiments. Furthermore, these cell lines are readily scalable for high-throughput screening, making them ideal for drug discovery and functional genomics.

By leveraging PARP8 Gene Knockout Cell Lines, researchers and clinicians can unlock new insights into PARP-related pathways, enhancing their chances of developing effective therapeutic agents. With our team of experts at the forefront of genetic engineering and cell line development, we provide not only high-quality products but also tailored support to help you achieve your research goals with confidence.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.